Assessing Align Technology’s (ALGN) Valuation Following Earnings Miss, Guidance Cut, and Leadership Shakeup

If you own or follow Align Technology (ALGN), you have likely noticed the uptick in headlines and questions swirling around the stock. After the company missed second quarter expectations, lowered its revenue guidance, and disclosed fresh legal scrutiny over its communications to investors, Wall Street’s attention is glued to what comes next. The situation escalated with word of major changes in the executive ranks and more than 37% wiped off the stock price, leaving many investors debating whether to bail, hold, or take advantage of any opportunity that arises from the turmoil.

The wave of bad news has only compounded an already tough year for Align. Over the past year, Align shares have lost nearly half their value, and they are down sharply both year-to-date and in the past three months. While leadership changes and new strategies, such as driving more volume in key dental channels, are meant to reset the growth narrative, most of the recent momentum has been moving in the wrong direction, inviting skepticism but also raising questions on long-term value.

The market reaction seems severe, but is it overdone, or is the discount justified by what lies ahead? Is the market aggressively pricing in further pain, or is this where value-minded investors should finally take a closer look?

Most Popular Narrative: 29.5% Undervalued

According to the most widely followed narrative, Align Technology stock is currently considered to be trading at a substantial discount to its fair value, with analysts projecting nearly 30% upside from current levels.

The continued expansion of clinical indications for Invisalign (such as Invisalign First for teens/kids and palate expanders) and the increasing adoption by general practitioner dentists are broadening Align's addressable market. This is positioning the company for higher long-term revenues and double-digit earnings growth as these new segments mature.

Eager to understand what sets this fair value estimate apart? The narrative hinges on aggressive growth forecasts and a future profit multiple that only a select group of companies ever achieve. Want to know what combination of expected market expansion and operational changes forms the backbone of this bullish outlook? Discover the surprising financial projections and assumptions driving the consensus analyst price target. These details may just change your perspective on whether Align’s current price signals a compelling opportunity or not.

Result: Fair Value of $186.36 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent macroeconomic uncertainty and a trend toward lower-priced aligner products could quickly undermine these bullish growth assumptions and valuation targets.

Find out about the key risks to this Align Technology narrative.

Another View: What Does Our DCF Model Say?

Taking a different approach, the SWS DCF model suggests Align Technology’s shares may be even further undervalued, which adds another layer to the debate. Does this challenge the market’s low expectations, or does it reinforce them?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Align Technology for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Align Technology Narrative

If you believe there’s more to Align’s story, or want to dig deeper into the numbers, you can shape your own perspective in just minutes. Do it your way

A great starting point for your Align Technology research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Ready for More Smart Stock Picks?

Don't leave your portfolio on autopilot. Get ahead with tailor-made investment ideas you might be missing. These strategies could transform your financial outlook this year.

• Spot unbeatable value, filter out overpriced names, and seize market inefficiencies through undervalued stocks based on cash flows. This highlights profit potential others overlook.
• Uncover the growth stories driving medical breakthroughs by tapping into cutting-edge trends with our healthcare AI stocks.
• Generate extra income and shore up your portfolio’s resilience using stocks screened for generous yields and steady payouts with the expert-curated dividend stocks with yields > 3%.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com